GeneXpert Testing: Applications for Clinical Microbiology, Part II

Elizabeth M. Marlowe, Donna M. Wolk

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The impact of rapid polymerase chain reaction (PCR) technology on infectious-disease testing is continuing to evolve outside the realm of a centralized laboratory. The GeneXpert Dx system is the first unit dose, near-point-of-care, molecular device commercially available. Part I of this two-part article addressed the use of the GeneXpert system for the detection of group B Streptococcus, enterovirus, and methicillin-resistant and methicillin-susceptible Staphylococcus aureus in various clinical specimens. Part II of this article will review the advantages and disadvantages of conventional culture methods and alternative molecular technologies along with the GeneXpert system, for the detection of these microorganisms in clinical specimens.

Original languageEnglish (US)
Pages (from-to)183-188
Number of pages6
JournalClinical Microbiology Newsletter
Volume30
Issue number24
DOIs
StatePublished - Dec 15 2008

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'GeneXpert Testing: Applications for Clinical Microbiology, Part II'. Together they form a unique fingerprint.

Cite this